Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Medical Device

FDA Chief Counsel Ralph Tyler To Depart In August

This article was originally published in The Gray Sheet

Executive Summary

Ralph Tyler is leaving FDA 18 months after becoming the agency's chief counsel.

You may also be interested in...



Incoming FDA Medical Products Official Has Strong Industry Ties

Former J&J executive Leona Brenner-Gati will become acting deputy commissioner for medical products and tobacco following the departure of Stephen Spielberg.

People In Brief

Spectranetics CEO

People In Brief

Spectranetics CEO

Table

View full table

Related Content

Medtech Insight

Topics

Tags:
Medical Device
Latest Headlines

FDA Issues Framework For Use Of Digital Health Technologies In Drug Development

FDA Finalizes Guidance Documents Aimed At Easing Post-Pandemic Regulatory Transitions

Podcast Special: J&J's Andrie Leday Addresses ASC Market With Customized Approach

Pivotal Opportunity For UK Medtech Must Not Be Wasted

See All
UsernamePublicRestriction

Register

MT030318

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By